Inovio Pharmaceuticals, Inc. (LON:0A43)
2.199
-0.020 (-0.90%)
At close: Jun 27, 2025
Inovio Pharmaceuticals Revenue
Inovio Pharmaceuticals had revenue of $65.34K USD in the quarter ending March 31, 2025. This brings the company's revenue in the last twelve months to $283.10K, down -60.52% year-over-year. In the year 2024, Inovio Pharmaceuticals had annual revenue of $217.76K, down -73.83%.
Revenue (ttm)
$283.10K
Revenue Growth
-60.52%
P/S Ratio
163.01
Revenue / Employee
$2.11K
Employees
134
Market Cap
35.72M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 217.76K | -614.25K | -73.83% |
Dec 31, 2023 | 832.01K | -9.43M | -91.89% |
Dec 31, 2022 | 10.26M | 8.49M | 478.23% |
Dec 31, 2021 | 1.77M | -5.64M | -76.05% |
Dec 31, 2020 | 7.41M | 3.30M | 80.24% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 42.56B |
Shell | 217.54B |
HSBC Holdings | 44.89B |
Unilever | 50.25B |
Rolls-Royce Holdings | 18.91B |
British American Tobacco p.l.c. | 25.87B |
Rio Tinto Group | 42.86B |
RELX PLC | 9.43B |
Inovio Pharmaceuticals News
- 7 weeks ago - Inovio Pharmaceuticals, Inc. (INO) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 2 months ago - Inovio Pharmaceuticals, Inc. (INO) Citizens JMP Life Sciences Conference (Transcript) - Seeking Alpha
- 2 months ago - INOVIO to Present at Upcoming Scientific and Investor Conferences - PRNewsWire
- 2 months ago - INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025 - PRNewsWire
- 3 months ago - INOVIO to Present at Upcoming Scientific Conferences - PRNewsWire
- 3 months ago - Inovio aims for INO-3107 regulatory submission by mid-2025 while addressing key manufacturing issues - Seeking Alpha
- 3 months ago - Q4 2024 Inovio Pharmaceuticals Inc Earnings Call Transcript - GuruFocus